Albuterol Improves Impaired Mucociliary Clearance After Lung Transplantation

Research output: Contribution to journalArticle

Abstract

Background: Previous studies have shown that mucociliary clearance (MCC) is diminished after lung transplantation. However, it is unknown how early this deficit occurs after transplantation, or whether the abnormality can be improved by pharmacologic means. We hypothesized that impairment of MCC is evident soon after lung transplantation and that the defect in MCC can be improved by inhaled β2-adrenergic receptor agonists. Methods: MCC and cough clearance (CC) were quantified in seven patients at 76 ± 48 days (mean ± standard deviation) after lung transplantation (baseline visit) and again 1 week later after an acute inhalation of albuterol. MCC was also determined once in four healthy subjects. To measure MCC, volunteers inhaled 99m-technetium-sulfur colloid aerosol, followed by gamma-camera imaging of their lungs for 76 minutes. Results: Baseline MCC was significantly reduced in transplant patients, compared with healthy subjects, averaging 8.9 ± 7.3% and 20.9 ± 15.1%, respectively (p = 0.05). CC was not affected by transplantation. Acute inhalation of albuterol significantly improved MCC in transplant patients (31.9 ± 21.9%) compared with baseline values (p <0.05). Conclusions: MCC is diminished within a few months after transplantation. However, the response to albuterol suggests that the deficit is not static and can be improved with inhalation of a β2-adrenergic receptor agonist.

Original languageEnglish (US)
Pages (from-to)138-144
Number of pages7
JournalJournal of Heart and Lung Transplantation
Volume26
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Mucociliary Clearance
Lung Transplantation
Albuterol
Inhalation
Adrenergic Agonists
Transplantation
Cough
Healthy Volunteers
Technetium Tc 99m Sulfur Colloid
Transplants
Aerosols
Radionuclide Imaging
Volunteers
Lung

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Albuterol Improves Impaired Mucociliary Clearance After Lung Transplantation. / Laube, Beth L; Karmazyn, Yauel J.; Orens, Jonathan B; Mogayzel, Peter.

In: Journal of Heart and Lung Transplantation, Vol. 26, No. 2, 02.2007, p. 138-144.

Research output: Contribution to journalArticle

@article{8e1c1b1ee2db49b2ad89d418dd9fe55b,
title = "Albuterol Improves Impaired Mucociliary Clearance After Lung Transplantation",
abstract = "Background: Previous studies have shown that mucociliary clearance (MCC) is diminished after lung transplantation. However, it is unknown how early this deficit occurs after transplantation, or whether the abnormality can be improved by pharmacologic means. We hypothesized that impairment of MCC is evident soon after lung transplantation and that the defect in MCC can be improved by inhaled β2-adrenergic receptor agonists. Methods: MCC and cough clearance (CC) were quantified in seven patients at 76 ± 48 days (mean ± standard deviation) after lung transplantation (baseline visit) and again 1 week later after an acute inhalation of albuterol. MCC was also determined once in four healthy subjects. To measure MCC, volunteers inhaled 99m-technetium-sulfur colloid aerosol, followed by gamma-camera imaging of their lungs for 76 minutes. Results: Baseline MCC was significantly reduced in transplant patients, compared with healthy subjects, averaging 8.9 ± 7.3{\%} and 20.9 ± 15.1{\%}, respectively (p = 0.05). CC was not affected by transplantation. Acute inhalation of albuterol significantly improved MCC in transplant patients (31.9 ± 21.9{\%}) compared with baseline values (p <0.05). Conclusions: MCC is diminished within a few months after transplantation. However, the response to albuterol suggests that the deficit is not static and can be improved with inhalation of a β2-adrenergic receptor agonist.",
author = "Laube, {Beth L} and Karmazyn, {Yauel J.} and Orens, {Jonathan B} and Peter Mogayzel",
year = "2007",
month = "2",
doi = "10.1016/j.healun.2006.11.005",
language = "English (US)",
volume = "26",
pages = "138--144",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Albuterol Improves Impaired Mucociliary Clearance After Lung Transplantation

AU - Laube, Beth L

AU - Karmazyn, Yauel J.

AU - Orens, Jonathan B

AU - Mogayzel, Peter

PY - 2007/2

Y1 - 2007/2

N2 - Background: Previous studies have shown that mucociliary clearance (MCC) is diminished after lung transplantation. However, it is unknown how early this deficit occurs after transplantation, or whether the abnormality can be improved by pharmacologic means. We hypothesized that impairment of MCC is evident soon after lung transplantation and that the defect in MCC can be improved by inhaled β2-adrenergic receptor agonists. Methods: MCC and cough clearance (CC) were quantified in seven patients at 76 ± 48 days (mean ± standard deviation) after lung transplantation (baseline visit) and again 1 week later after an acute inhalation of albuterol. MCC was also determined once in four healthy subjects. To measure MCC, volunteers inhaled 99m-technetium-sulfur colloid aerosol, followed by gamma-camera imaging of their lungs for 76 minutes. Results: Baseline MCC was significantly reduced in transplant patients, compared with healthy subjects, averaging 8.9 ± 7.3% and 20.9 ± 15.1%, respectively (p = 0.05). CC was not affected by transplantation. Acute inhalation of albuterol significantly improved MCC in transplant patients (31.9 ± 21.9%) compared with baseline values (p <0.05). Conclusions: MCC is diminished within a few months after transplantation. However, the response to albuterol suggests that the deficit is not static and can be improved with inhalation of a β2-adrenergic receptor agonist.

AB - Background: Previous studies have shown that mucociliary clearance (MCC) is diminished after lung transplantation. However, it is unknown how early this deficit occurs after transplantation, or whether the abnormality can be improved by pharmacologic means. We hypothesized that impairment of MCC is evident soon after lung transplantation and that the defect in MCC can be improved by inhaled β2-adrenergic receptor agonists. Methods: MCC and cough clearance (CC) were quantified in seven patients at 76 ± 48 days (mean ± standard deviation) after lung transplantation (baseline visit) and again 1 week later after an acute inhalation of albuterol. MCC was also determined once in four healthy subjects. To measure MCC, volunteers inhaled 99m-technetium-sulfur colloid aerosol, followed by gamma-camera imaging of their lungs for 76 minutes. Results: Baseline MCC was significantly reduced in transplant patients, compared with healthy subjects, averaging 8.9 ± 7.3% and 20.9 ± 15.1%, respectively (p = 0.05). CC was not affected by transplantation. Acute inhalation of albuterol significantly improved MCC in transplant patients (31.9 ± 21.9%) compared with baseline values (p <0.05). Conclusions: MCC is diminished within a few months after transplantation. However, the response to albuterol suggests that the deficit is not static and can be improved with inhalation of a β2-adrenergic receptor agonist.

UR - http://www.scopus.com/inward/record.url?scp=33846391926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846391926&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2006.11.005

DO - 10.1016/j.healun.2006.11.005

M3 - Article

C2 - 17258147

AN - SCOPUS:33846391926

VL - 26

SP - 138

EP - 144

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 2

ER -